Find out more about Zhen Siow's experience
Zhen Siow's highlights
Displaying the 2 most recent scholarly works from 2 for Zhen Siow.
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer
Sheau W Lok, James R Whittle, Francois Vaillant, Charis E Teh, Louisa L Lo, Antonia N Policheni, Alice RT Bergin, Jayesh Desai, Sarah Ftouni, Luke C Gandolfo, Danny Liew, He K Liu, G Bruce Mann, Kate Moodie, Anand Murugasu, Bhupinder Pal, Andrew W Roberts, Mark A Rosenthal, Kylie Shackleton, Maria Joao Silva, et al.
Journal article | 2019 | CANCER DISCOVERY
Venetoclax, a potent and selective BCL2 inhibitor, synergizes with endocrine therapy in preclinical models of ER-positive breast c..
Spotlight on the utility of the Oncotype DX (R) breast cancer assay
Zhen Rong Siow, Richard H De Boer, Geoffrey J Lindeman, G Bruce Mann
Journal article | 2018 | INTERNATIONAL JOURNAL OF WOMENS HEALTH
The Oncotype DX® assay was developed to address the need for optimizing the selection of adjuvant systemic therapy for patients wi..
Medical Biology (w.e.h.i.)